Literature DB >> 28573337

Immunological characterization of a rigid α-Tn mimetic on murine iNKT and human NK cells.

Silvia Fallarini1, Alvaro Brittoli1, Michele Fiore2, Grazia Lombardi1, Olivier Renaudet3,4, Barbara Richichi5, Cristina Nativi6.   

Abstract

The ability of a rigid α-Tn mimetic (compound 1) to activate murine invariant natural killer T (iNKT) and human natural killer (NK) cells, two subsets of lymphocytes involved in cancer immunesurveillance, was investigated. For this purpose, the mimetic 1 was properly conjugated to a stearic acid containing glycerol-based phospholipid (compound 5) to be presented, in the context of the conserved non polymorphic major histocompatibility complex class I-like molecules (CD1d), to iNKT cells. On the contrary, the mimetic 1 was conjugated to a multivalent peptide-based scaffold (compound 6) to induce NK cell activation.

Entities:  

Keywords:  Glycomimetic; Immunotherapy; Invariant natural killer T cells; Natural killer cells; α-Tn antigen

Mesh:

Substances:

Year:  2017        PMID: 28573337     DOI: 10.1007/s10719-017-9775-6

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  57 in total

1.  Bacteriology: a caring culture.

Authors:  Sarah DeWeerdt
Journal:  Nature       Date:  2013-12-19       Impact factor: 49.962

Review 2.  Combining immunotherapy and targeted therapies in cancer treatment.

Authors:  Matthew Vanneman; Glenn Dranoff
Journal:  Nat Rev Cancer       Date:  2012-03-22       Impact factor: 60.716

3.  Interleukin-2 augments natural killer cell activity.

Authors:  C S Henney; K Kuribayashi; D E Kern; S Gillis
Journal:  Nature       Date:  1981-05-28       Impact factor: 49.962

Review 4.  Immune surveillance of tumors.

Authors:  Jeremy B Swann; Mark J Smyth
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

Review 5.  Recognition of CD1d-restricted antigens by natural killer T cells.

Authors:  Jamie Rossjohn; Daniel G Pellicci; Onisha Patel; Laurent Gapin; Dale I Godfrey
Journal:  Nat Rev Immunol       Date:  2012-11-16       Impact factor: 53.106

6.  Selective modulation of human natural killer cells in vivo after prolonged infusion of low dose recombinant interleukin 2.

Authors:  M A Caligiuri; C Murray; M J Robertson; E Wang; K Cochran; C Cameron; P Schow; M E Ross; T R Klumpp; R J Soiffer
Journal:  J Clin Invest       Date:  1993-01       Impact factor: 14.808

7.  Alpha-O-linked glycopeptide mimetics: synthesis, conformation analysis, and interactions with viscumin, a galactoside-binding model lectin.

Authors:  Jesús Jiménez-Barbero; Elisa Dragoni; Chiara Venturi; Federico Nannucci; Ana Ardá; Marco Fontanella; Sabine André; Francisco Javier Cañada; Hans-Joachim Gabius; Cristina Nativi
Journal:  Chemistry       Date:  2009-10-12       Impact factor: 5.236

Review 8.  Oxime ligation: a chemoselective click-type reaction for accessing multifunctional biomolecular constructs.

Authors:  Sébastien Ulrich; Didier Boturyn; Alberto Marra; Olivier Renaudet; Pascal Dumy
Journal:  Chemistry       Date:  2013-12-02       Impact factor: 5.236

9.  Determination of cellular lipids bound to human CD1d molecules.

Authors:  Daryl Cox; Lisa Fox; Runying Tian; Wilfried Bardet; Matthew Skaley; Danijela Mojsilovic; Jenny Gumperz; William Hildebrand
Journal:  PLoS One       Date:  2009-05-05       Impact factor: 3.240

Review 10.  The trafficking of natural killer cells.

Authors:  Claude Grégoire; Lionel Chasson; Carmelo Luci; Elena Tomasello; Frédéric Geissmann; Eric Vivier; Thierry Walzer
Journal:  Immunol Rev       Date:  2007-12       Impact factor: 12.988

View more
  2 in total

Review 1.  Recent advances on smart glycoconjugate vaccines in infections and cancer.

Authors:  Marko Anderluh; Francesco Berti; Anna Bzducha-Wróbel; Fabrizio Chiodo; Cinzia Colombo; Federica Compostella; Katarzyna Durlik; Xhenti Ferhati; Rikard Holmdahl; Dragana Jovanovic; Wieslaw Kaca; Luigi Lay; Milena Marinovic-Cincovic; Marco Marradi; Musa Ozil; Laura Polito; Josè Juan Reina; Celso A Reis; Robert Sackstein; Alba Silipo; Urban Švajger; Ondřej Vaněk; Fumiichiro Yamamoto; Barbara Richichi; Sandra J van Vliet
Journal:  FEBS J       Date:  2021-06-01       Impact factor: 5.622

2.  A Structurally Simple Vaccine Candidate Reduces Progression and Dissemination of Triple-Negative Breast Cancer.

Authors:  Amedeo Amedei; Fatemeh Asadzadeh; Francesco Papi; Maria Giuliana Vannucchi; Veronica Ferrucci; Iris A Bermejo; Marco Fragai; Carolina Vieira De Almeida; Linda Cerofolini; Stefano Giuntini; Mauro Bombaci; Elisa Pesce; Elena Niccolai; Francesca Natali; Eleonora Guarini; Frank Gabel; Chiara Traini; Stefano Catarinicchia; Federica Ricci; Lorenzo Orzalesi; Francesco Berti; Francisco Corzana; Massimo Zollo; Renata Grifantini; Cristina Nativi
Journal:  iScience       Date:  2020-06-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.